Use of endothelial-leukocyte adhesion molecule-1 and...

Details Use of endothelial-leukocyte adhesion molecule-1 and... Use of endothelial-leukocyte adhesion molecule-1 and...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/70 (2006.01) A61K 38/17 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C12P 19/44 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2083273

A B S T R A C T A method for treating asthma in a patient using an agent selected from the group consisting of: (a) an antibody capable of binding to ELAM-1; (b) a fragment of the antibody (a), the fragment being capable of binding to ELAM-1; (c) ELAM-1, belng substantially free of natural contaminants; (d) a functional derivative of ELAM-1; (e) an antibody capable of binding to an ELAM-1 receptor; (f) a fragment of the antibody (e), the fragment being capable of binding to an ELAM-1 receptor; (g) an ELAM-1 receptor, being substantially free of natural contaminants; and (h) a functional derivative of an ELAM-1 receptor. CASE 9/066 20

Affiliated with

Also associated with

Rating

Use of endothelial-leukocyte adhesion molecule-1 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of endothelial-leukocyte adhesion molecule-1 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of endothelial-leukocyte adhesion molecule-1 and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1471154